Menu Search
Equities

Fine Foods & Pharmaceuticals NTM SpA

FF:MIL

Fine Foods & Pharmaceuticals NTM SpA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)8.14
  • Today's Change-0.10 / -1.21%
  • Shares traded2.62k
  • 1 Year change+6.82%
  • Beta0.4849
Data delayed at least 15 minutes, as of Nov 08 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy1
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in EUR

The 2 analysts offering 12 month price targets for Fine Foods & Pharmaceuticals NTM SpA have a median target of 12.30, with a high estimate of 12.50 and a low estimate of 12.00. The median estimate represents a 51.11% increase from the last price of 8.14.
High53.6%12.50
Med51.1%12.30
Low47.4%12.00

Dividends

In 2023, Fine Foods & Pharmaceuticals NTM SpA reported a dividend of 0.12 EUR. The 2 analysts covering the company expect dividends of 0.12 EUR for the upcoming fiscal year, a decrease of 0.83%.
Div growth (TTM)--
More ▼

Earnings history & estimates in EUR

Fine Foods & Pharmaceuticals NTM SpA reported annual 2023 earnings of 0.19 per share on Mar 29, 2024.
Average growth rate+9.36%
More ▼

Revenue history & estimates in EUR

Fine Foods & Pharmaceuticals N.T.M. S.p.A. had revenues for the full year 2023 of 252.91m. This was 21.40% above the prior year's results.
Average growth rate+12.83%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.